Hui-Wen Lo, Ph.D.
Affiliations: | 2002 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Hui-Wen Lo"Parents
Sign in to add mentorFrancis Ali-Osman | grad student | 2002 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
(Signaling pathways in the transcriptional and post-translational regulation of the human glutathione S -transferase P1 gene.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Manore S, Zhuang C, Najjar MK, et al. (2024) Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers. Cells. 13 |
Najjar MK, Khan MS, Zhuang C, et al. (2024) Interleukin-1 Receptor-Associated Kinase 1 in Cancer Metastasis and Therapeutic Resistance: Mechanistic Insights and Translational Advances. Cells. 13 |
Regua AT, Bindal S, Najjar MK, et al. (2024) Dual inhibition of the TrkA and JAK2 pathways using entrectinib and pacritinib suppresses the growth and metastasis of HER2-positive and triple-negative breast cancers. Cancer Letters. 597: 217023 |
Doheny D, Sirkisoon S, Carpenter RL, et al. (2024) Correction: Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Oncogene |
Song Q, Ruiz J, Xing F, et al. (2023) Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment. Communications Biology. 6: 760 |
Arrigo A, Regua AT, Najjar MK, et al. (2023) Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy. Cancers. 15 |
Doheny D, Manore S, Sirkisoon SR, et al. (2022) An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1. Cancers. 14 |
Wong GL, Manore SG, Doheny DL, et al. (2022) STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges. Seminars in Cancer Biology |
Regua AT, Najjar M, Lo HW. (2022) RET signaling pathway and RET inhibitors in human cancer. Frontiers in Oncology. 12: 932353 |
Regua AT, Aguayo NR, Jalboush SA, et al. (2021) TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers. 13 |